Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes

Protein synthesis and autophagic degradation are regulated in an opposite manner by mammalian target of rapamycin (mTOR), whereas under certain conditions it would be beneficial if they occurred in unison to handle rapid protein turnover. We observed a distinct cellular compartment at the trans side...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 332; no. 6032; pp. 966 - 970
Main Authors Narita, Masako, Young, Andrew R. J., Arakawa, Satoko, Samarajiwa, Shamith A., Nakashima, Takayuki, Yoshida, Sei, Hong, Sungki, Berry, Lorraine S., Reichelt, Stefanie, Ferreira, Manuela, Tavaré, Simon, Inoki, Ken, Shimizu, Shigeomi, Narita, Masashi
Format Journal Article
LanguageEnglish
Published Washington, DC American Association for the Advancement of Science 20.05.2011
The American Association for the Advancement of Science
Subjects
Online AccessGet full text
ISSN0036-8075
1095-9203
1095-9203
DOI10.1126/science.1205407

Cover

More Information
Summary:Protein synthesis and autophagic degradation are regulated in an opposite manner by mammalian target of rapamycin (mTOR), whereas under certain conditions it would be beneficial if they occurred in unison to handle rapid protein turnover. We observed a distinct cellular compartment at the trans side of the Golgi apparatus, the TOR-autophagy spatial coupling compartment (TASCC), where (auto)lysosomes and mTOR accumulated during Ras-induced senescence. mTOR recruitment to the TASCC was amino acid— and Rag guanosine triphosphatase—dependent, and disruption of mTOR localization to the TASCC suppressed interleukin-6/8 synthesis. TASCC formation was observed during macrophage differentiation and in glomerular podocytes; both displayed increased protein secretion. The spatial coupling of cells' catabolic and anabolic machinery could augment their respective functions and facilitate the mass synthesis of secretory proteins.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
Present address: Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, 1649-028 Lisbon, Portugal
Present address: Kyowa Hakko Kirin Co. Ltd., Shizuoka 411-8731, Japan
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.1205407